# POLYOXYL 40 STEARATE TYPE I

URL: https://app.greenveil.ai/ingredients/ingredient_dtxsid_dtxsid6027715
Categories: beauty, cleaning, food, industrial, pharma
Functions: Anti-static agent, Cleaning agent, Defoamer, Dispersing agent, Emulsifier, Fragrance, Humectant, Lubricating agent, Solvent, Surfactant (surface active agent), Thickening agent, anti-fogging agents
Identifier: DTXSID6027715

> POLYOXYL 40 STEARATE TYPE I is used as anti-static agent / cleaning agent. EPA CPDat observed this chemical in 2753 composition records across product categories including Personal care, Laboratory supplies, Food and drug. Assessed from 70 sources.

## Safety assessment

- Chemical concern: not yet assessed
- Rationale: EPA CPDat observed this chemical in 2753 composition records across product categories including Personal care, Laboratory supplies, Food and drug.

## Regulatory status

- US: commercial use observed — EPA CPDat observed this chemical in 2753 composition records across product categories including Personal care, Laboratory supplies, Food and drug. EPA CPDat classifies this chemical for functional uses including Solvent, Surfactant (surface active agent), Cleaning agent.
- US: inactive ingredient database — Route: TOPICAL; Dosage form: CREAM; Maximum daily exposure: 552 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: LOTION; Potency: 1 %w/w
- US: inactive ingredient database — Route: VAGINAL; Dosage form: CREAM; Maximum daily exposure: 100 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CONCENTRATE; Potency: 25 mg/5ml
- US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 60 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: CREAM; Maximum daily exposure: 229 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: SPONGE; Potency: NA
- US: inactive ingredient database — Route: AURICULAR (OTIC); Dosage form: SUSPENSION; Potency: 1 %w/v
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: OINTMENT; Potency: NA
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SOLUTION; Potency: 7 %w/w
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SUSPENSION; Potency: 0.5 %w/v
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 14 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: GRANULE; Potency: NA
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET; Potency: 8.48 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FILM COATED; Potency: 2 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: AEROSOL, FOAM; Potency: 2.83 %w/w
- US: inactive ingredient database — Route: TOPICAL; Dosage form: CREAM; Maximum daily exposure: 50 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: LOTION; Potency: 3 %w/w
- US: inactive ingredient database — Route: TOPICAL; Dosage form: OINTMENT; Potency: NA
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as polymer.
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as mixture.

_Assessed by Greenveil._